1
|
Dhillon P, Amir E, Lo M, Kitchlu A, Chan C, Cochlin S, Yip P, Chen E, Lee R, Ng P. A case–control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity. J Oncol Pharm Pract 2018; 25:875-883. [DOI: 10.1177/1078155218771461] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Background Mannitol is an osmotic diuretic given routinely as part of cisplatin regimens to prevent nephrotoxicity, but there are limited data on the ideal dosage. At our center, three different doses of mannitol are used: 12, 20, and 40 g per cycle for cisplatin doses of ≥50 mg/m2. The primary objective was to determine if variations in mannitol dosing significantly influence the incidence of cisplatin-induced acute nephrotoxicity. Methods A case–control study was performed. Electronic records of 1462 consecutive outpatients who received cisplatin at ≥ 50 mg/m2 per cycle between January 2010 and December 2014 were reviewed. Patients experiencing nephrotoxicity of any grade within 30 days of last cisplatin dose, as defined by NCI CTCAE 4.0, were matched to a minimum of two and maximum of five controls based on the following criteria: age ± 5 years, baseline estimated glomerular filtration rate ± 10 ml/min/1.73 m2, cisplatin dose per cycle, and presence of diabetes. Conditional logistic regression was used to identify baseline predictors of cisplatin-induced acute nephrotoxicity. Results Of the 1245 included patients, 237 had nephrotoxicity and 1008 were matched controls. Median baseline estimated glomerular filtration rate for cases and controls were 83 and 80 ml/min/1.73 m2, respectively. A total of 3.8% of cases experienced ≥ grade 3 nephrotoxicity. Univariable analysis showed that diabetes, lymphoma, low baseline estimated glomerular filtration rate, and low baseline magnesium level were significantly associated with nephrotoxicity, whereas mannitol dosing did not show any association (odds ratio 1.08; p = 0.29). In multivariable analysis, diabetes and lymphoma retained statistical significance, but baseline estimated glomerular filtration rate and baseline magnesium level showed nonsignificant associations with nephrotoxicity. Conclusions Cisplatin-induced acute nephrotoxicity remains common in patients with good baseline renal function despite preventive measures. Diabetes and lymphoma are predictors of nephrotoxicity, whereas mannitol dosing has no significant influence, suggesting that doses may be standardized across cisplatin regimens.
Collapse
Affiliation(s)
- Patwant Dhillon
- Department of Pharmacy, Princess Margaret Cancer Centre, UHN, Toronto, Canada
| | - Eitan Amir
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, UHN, Toronto, Canada
- Department of Medicine, University of Toronto, Toronto, Canada
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
| | - Melissa Lo
- Department of Pharmacy, Princess Margaret Cancer Centre, UHN, Toronto, Canada
| | - Abhijat Kitchlu
- Department of Medicine, University of Toronto, Toronto, Canada
- Division of Nephrology, Toronto General Hospital, UHN, Toronto, Canada
| | - Christopher Chan
- Department of Medicine, University of Toronto, Toronto, Canada
- Division of Nephrology, Toronto General Hospital, UHN, Toronto, Canada
| | - Stephen Cochlin
- Laboratory Medicine Program, Toronto General Hospital, UHN, Toronto, Canada
| | - Paul Yip
- Laboratory Medicine Program, Toronto General Hospital, UHN, Toronto, Canada
| | - Eric Chen
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, UHN, Toronto, Canada
- Department of Medicine, University of Toronto, Toronto, Canada
| | - Roy Lee
- Department of Pharmacy, Princess Margaret Cancer Centre, UHN, Toronto, Canada
| | - Pamela Ng
- Department of Pharmacy, Princess Margaret Cancer Centre, UHN, Toronto, Canada
| |
Collapse
|
2
|
Mitome T, Furuya K, Imano M, Osaka K, Yokomizo Y, Hayashi N, Nakaigawa N, Yamanaka S, Yao M. Bilateral renal lymphoma: rapid recovery from an acute kidney injury after open renal biopsy. Clin Case Rep 2016; 4:5-8. [PMID: 26783426 PMCID: PMC4706393 DOI: 10.1002/ccr3.401] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2015] [Revised: 08/13/2015] [Accepted: 08/27/2015] [Indexed: 12/31/2022] Open
Abstract
Renal lymphoma as an initial lesion is relatively rare. Bilateral renal lymphoma frequently presents as acute kidney injury. With systematic chemotherapy for the lymphoma, patients usually recover their kidney function. However, in the case we describe here, the patient's kidney function recovered greatly after an open renal biopsy. Here, we review and discuss this unique case.
Collapse
Affiliation(s)
- Taku Mitome
- Department of Urology Yokohama City University Graduate School of Medicine Yokohama Kanagawa Japan
| | - Kazuhiro Furuya
- Department of Urology Yokohama City University Graduate School of Medicine Yokohama Kanagawa Japan
| | - Masashi Imano
- Department of Urology Yokohama City University Graduate School of Medicine Yokohama Kanagawa Japan
| | - Kimito Osaka
- Department of Urology Yokohama City University Graduate School of Medicine Yokohama Kanagawa Japan
| | - Yumiko Yokomizo
- Department of Urology Yokohama City University Graduate School of Medicine Yokohama Kanagawa Japan
| | - Narihiko Hayashi
- Department of Urology Yokohama City University Graduate School of Medicine Yokohama Kanagawa Japan
| | - Noboru Nakaigawa
- Department of Urology Yokohama City University Graduate School of Medicine Yokohama Kanagawa Japan
| | - Shoji Yamanaka
- Department of Pathology Yokohama City University Hospital Yokohama Kanagawa Japan
| | - Masahiro Yao
- Department of Urology Yokohama City University Graduate School of Medicine Yokohama Kanagawa Japan
| |
Collapse
|